๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hereditary defects and conservation genetic management of captive populations

โœ Scribed by Linda Laikre


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
115 KB
Volume
18
Category
Article
ISSN
0733-3188

No coin nor oath required. For personal study only.

โœฆ Synopsis


The occurrence of hereditary disorders in conservation breeding programs may severely hamper the overall aim of such programs. The obstacles that arise in this context and the particular management strategies needed to deal with the problems are yet to be adequately addressed. Results from a literature review indicate that hereditary disorders may be fairly common in zoo populations. An example with albinism in a captive brown bear population bred in Nordic zoos is presented. It is demonstrated that the segregation pattern is consistent with an autosomal recessive allele, and carrier probabilities of live animals indicate that the allele occurs in high frequency in the present population. Removing animals with a probability of carrying the allele will result in loss of founder alleles considered particularly valuable.


๐Ÿ“œ SIMILAR VOLUMES


Clinical impact of molecular genetic dia
โœ Henry T. Lynch; Patrice Watson; Trudy G. Shaw; Jane F. Lynch; Anne E. Harty; Bar ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 3 views

Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10% of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of wh

Clinical impact of molecular genetic dia
โœ Henry T. Lynch; Patrice Watson; Trudy G. Shaw; Jane F. Lynch; Anne E. Harty; Bar ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB ๐Ÿ‘ 3 views

Hereditary cancer represents approximately 5-10% of the total cancer burden and may account for 60,000 to 120,000 new cancer occurrences this year in the United States. New developments in molecular genetics and the cloning of cancer-prone genes have intensely fueled interest in dealing with heredit